0001628280-24-024972.txt : 20240523 0001628280-24-024972.hdr.sgml : 20240523 20240523163423 ACCESSION NUMBER: 0001628280-24-024972 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Breeden Richard C CENTRAL INDEX KEY: 0001300622 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38848 FILM NUMBER: 24978897 MAIL ADDRESS: STREET 1: 100 SOUTH WACKER STREET 2: SUITE 1800 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STERIS plc CENTRAL INDEX KEY: 0001757898 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 35312322000 MAIL ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: STERIS Ltd DATE OF NAME CHANGE: 20181101 4 1 wk-form4_1716496445.xml FORM 4 X0508 4 2024-05-21 0 0001757898 STERIS plc STE 0001300622 Breeden Richard C C/O 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 IRELAND 1 0 0 0 0 Ordinary Shares 2024-05-21 4 M 0 4584 51.53 A 32554 D Ordinary Shares 27242 I See Footnotes Below Director Stock Option (right to buy) 51.53 2024-05-21 4 M 0 4584 0 D 2024-08-06 Ordinary Shares 4584 0 D Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund"). Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,359 of these shares held by Breeden Partnership LLP. This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2024-05-23